TRANSPULMONARY SYSTEMIC COOLING USING LIQUID MISTS

• US 20090165786A1
• Filed: 03/04/2009
• Published: 07/02/2009
• Est. Priority Date: 01/09/2004
• Status: Abandoned Application

• Current Assignee: Benechill, Inc. (Braincool Ab)
• Original Assignee: Benechill, Inc. (Braincool Ab)
• Inventors: Shaffer, Thomas H., Barbut, Denise R., Rozenberg, Allan
• Application Number:
  US12/398,123
• Publication Number:
  US 20090165786A1
• Time in Patent Office: Days
• US Class Current: 128/203.120
• CPC Class Codes: A61F 2007/0063 for cooling
• CPC Class Codes: A61F 2007/0065 Causing evaporation
• CPC Class Codes: A61F 7/10 Cooling bags, e.g. ice-bags
• CPC Class Codes: A61F 7/12 Devices for heating or cooling internal body cavities

Abstract

A method for transpulmonary cooling by providing a liquid having a boiling point of 38-300° C., more preferably 38-250° C., more preferably 38-200° C., more preferably 38-150° C., more preferably 38-80° C. The liquid is nebulized to form a mist. The mist is optionally cooled below room temperature and delivered to the airway of a patient so that the patient inhales the mist. The mist causes systemic cooling by evaporative heat loss when inhaled at room temperature and additionally by direct heat transfer when inhaled below room temperature. Compositions and medical devices for transpulmonary cooling are also provided.

Claims

1. A method for transpulmonary cooling, comprising the steps of,

selecting a patient suffering from stroke, head trauma, myocardial infarction, or cardiogenic shock;

providing a liquid having a boiling point of 38-300°

C.;

nebulizing the liquid to form a mist; and

delivering the mist to the airway of a patient so that the patient inhales the mist to cause systemic cooling,

wherein delivering the mist is continued until the systemic temperature is reduced to about 35°

C. or below.

2. The method of claim 1, wherein the mist delivered to the airway of a patient further comprises saline mist.

3. The method of claim 1, wherein the mist delivered to the airway of a patient further comprises a pulmonary vasodilator.

4. The method of claim 3, wherein the pulmonary vasodilator is selected from the group consisting of nitric oxide, nitric oxide/oxygen, nitric oxide/air, and nitric oxide/fluorinated gas.

5. The method of claim 1, wherein the mist delivered to the airway of a patient further comprises an agent that maintains normal cerebral vascular tone.

6. The method of claim 5, wherein the agent is carbon dioxide,

7. The method of claim 1, further comprising the steps of:

terminating the delivery of the mist to the airway of a patient after a period of more than 3 seconds of delivering the mist to the airway of a patient;

delivering a dry gas to the airway of a patient so that the patient inhales the dry gas for a period of more than 3 seconds;

terminating the delivery of the dry gas to the airway of a patient;

delivering the mist to the airway of a patient so that the patient inhales the mist to cause systemic cooling.

8. The method of claim 7, wherein the dry gas is selected from the group consisting of cold dry air, cold dry helium-oxygen mixture, and cold dry sulfur hexafluoride.

9. A method for transpulmonary cooling, comprising the steps of;

selecting a patient suffering from cerebral ischemia;

providing a liquid having a boiling point of 38-300°

C.;

nebulizing the liquid to form a mist; and

delivering the mist to the airway of a patient so that the patient inhales the mist to cause systemic cooling,

wherein delivering the mist is continued until the systemic temperature is reduced to about 35°

C. or below.

10. The method of claim 9, wherein the mist delivered to the airway of a patient further comprises saline mist.

11. The method of claim 9, wherein the mist delivered to the airway of a patient further comprises a pulmonary vasodilator.

12. The method of claim 11, wherein the pulmonary vasodilator is selected from the group consisting of nitric oxide, nitric oxide/oxygen, nitric oxide/air, and nitric oxide/fluorinated gas.

13. The method of claim 9, wherein the mist delivered to the airway of a patient further comprises all agent that maintains normal cerebral vascular tone.

14. The method of claim 13, wherein the agent is carbon dioxide.

15. The method of claim 9, further comprising the steps of:

terminating the delivery of the mist to the airway of a patient after a period of more than 3 seconds of delivering the mist to the airway of a patient;

delivering a dry gas to the airway of a patient so that the patient inhales the dry gas for a period of more than 3 seconds;

terminating the delivery of the dry gas to the airway of a patient;

delivering the mist to the airway of a patient so that the patient inhales the mist to cause systemic cooling.

16. The method of claim 15, wherein the dry gas is selected from the group consisting of cold dry air, cold dry helium-oxygen mixture, and cold dry sulfur hexafluoride.